Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

Clinical trial NCT02354001 · COMPLETED

Trial details

NCT number: NCT02354001
Sponsor: The Alfred
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2011-04-01
Primary completion: 2019-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.